Arbutus Biopharma
ABUS
ABUS
65 hedge funds and large institutions have $75.5M invested in Arbutus Biopharma in 2020 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 16 closing their positions.
Holders
65
Holders Change
+14
Holders Change %
+27.45%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
9
Reduced
16
Closed
16
Calls
$1.5M
Puts
$1.87M
Net Calls
-$373K
Net Calls Change
-$1.58M
Top Buyers
Top Sellers
1 |
CAC
1
Cowen and Company
New York
|
$1.48M |
2 |
2
Goldman Sachs
New York
|
$795K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$219K |
4 |
RI
4
RTW Investments
New York
|
$18.7M |
5 |
5
Morgan Stanley
New York
|
$9.11M |